Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Steris Corp (STE)

Steris Corp (STE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,575,419
  • Shares Outstanding, K 84,552
  • Annual Sales, $ 2,782 M
  • Annual Income, $ 304,050 K
  • 60-Month Beta 1.00
  • Price/Sales 4.50
  • Price/Cash Flow 19.45
  • Price/Book 3.93

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 1.11
  • Number of Estimates 3
  • High Estimate 1.12
  • Low Estimate 1.11
  • Prior Year 1.00
  • Growth Rate Est. (year over year) +11.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
140.36 +5.68%
on 06/17/19
154.09 -3.74%
on 07/03/19
+7.90 (+5.63%)
since 06/14/19
3-Month
119.62 +24.00%
on 04/17/19
154.09 -3.74%
on 07/03/19
+23.13 (+18.47%)
since 04/16/19
52-Week
99.14 +49.61%
on 12/26/18
154.09 -3.74%
on 07/03/19
+38.61 (+35.19%)
since 07/16/18

Most Recent Stories

More News
Insulet (PODD) Soars to 52-Week High, Time to Cash Out?

Insulet (PODD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

NURO : 0.42 (-4.55%)
COO : 329.72 (-0.67%)
STE : 148.52 (-0.14%)
PODD : 119.84 (-0.71%)
TFX or STE: Which is a Better Investment Pick Right Now?

STERIS (STE) scores higher than Teleflex (TFX) when it comes to valuation and one-year price performance.

STE : 148.52 (-0.14%)
NUVA : 57.36 (-0.21%)
TFX : 332.75 (-0.66%)
PEN : 170.21 (-1.46%)
STERIS (STE) Q4 Earnings Surpass Estimates, Margins Rise

STERIS (STE) witnesses solid revenue growth across each of its operating segments in the reported quarter.

STE : 148.52 (-0.14%)
MASI : 152.21 (-1.44%)
XRAY : 56.62 (-0.82%)
CNMD : 85.96 (-0.53%)
STERIS Announces Financial Results for Fiscal 2019 Fourth Quarter and Full Year

-- Strong fourth quarter revenue growth

STE : 148.52 (-0.14%)
Steris (STE) Q4 Earnings and Revenues Surpass Estimates

Steris (STE) delivered earnings and revenue surprises of 6.25% and 4.62%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

STE : 148.52 (-0.14%)
What's in Store for Aurora Cannabis (ACB) in Q3 Earnings?

Continued execution of consumer and medical strategies, launch of new products and strong international footprint are likely to aid Aurora Cannabis (ACB) in Q3.

ACB : 7.18 (+2.43%)
LULU : 189.18 (+0.01%)
STE : 148.52 (-0.14%)
HEXO : 5.07 (+0.40%)
Steris (STE) Earnings Expected to Grow: Should You Buy?

Steris (STE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

STE : 148.52 (-0.14%)
Market Trends Toward New Normal in Enersys, Globalstar, STERIS plc, and Enova International -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Enersys (NYSE:ENS), Globalstar,...

ENVA : 21.68 (+2.65%)
STE : 148.52 (-0.14%)
ENS : 65.57 (+0.12%)
GSAT : 0.43 (-2.27%)
Can Core Business Unit Fuel McKesson (MCK) Q4 Earnings?

Anticipated growth across core business unit and solid show by Medical Surgical and European Pharmaceutical Solutions is likely to aid McKesson's (MCK) Q4 earnings. However, rising costs might be a dampener....

ACB : 7.18 (+2.43%)
MCK : 142.20 (-0.36%)
STE : 148.52 (-0.14%)
NSTG : 30.00 (-0.43%)
What's in Store for Cardinal Health (CAH) in Q3 Earnings?

Better-than-expected performance at Pharmaceutical and Medical segments and diverse product portfolio is likely to aid Cardinal Health (CAH) in Q3 earnings. However, stiff competition might play spoilsport....

ACB : 7.18 (+2.43%)
STE : 148.52 (-0.14%)
CAH : 46.64 (-1.81%)
NSTG : 30.00 (-0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade STE with:

Business Summary

Steris Plc provide infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial and governmental customers. The Company's operating segments consists of Healthcare, Life Sciences and STERIS...

See More

Key Turning Points

2nd Resistance Point 151.29
1st Resistance Point 150.01
Last Price 148.52
1st Support Level 147.11
2nd Support Level 145.49

See More

52-Week High 154.09
Last Price 148.52
Fibonacci 61.8% 133.10
Fibonacci 50% 126.62
Fibonacci 38.2% 120.13
52-Week Low 99.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar